<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Antibodies to ß(2) <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (IgG and IgM isotypes) have recently been added to the laboratory criteria of the revised <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> classification criteria </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether IgM anti-ß(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-ß(2)-GPI) is associated with clinical manifestations of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Anti-ß(2)-GPI was measured in 796 patients with SLE (93% women, 53% white, 38% African American, mean age 45 yrs) </plain></SENT>
<SENT sid="3" pm="."><plain>IgM anti-ß(2)-GPI (&gt; 20 phospholipid units) was found in 16% </plain></SENT>
<SENT sid="4" pm="."><plain>Associations were determined with clinical manifestations of SLE and with components of the Systemic <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> International Collaborating Clinics/American College of Rheumatology Damage Index </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: As expected, IgM anti-ß(2)-GPI was highly associated with both the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and with anticardiolipin </plain></SENT>
<SENT sid="6" pm="."><plain>It was associated with <z:hpo ids='HP_0002326'>transient ischemic attack</z:hpo> (OR 2.64, p = 0.04), but not significantly with venous or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>IgM anti-ß(2)-GPI was protective against <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> (OR 0.54, p = 0.049), renal damage (p = 0.019), and <z:hpo ids='HP_0000822'>hypertension</z:hpo> (OR 0.58, p = 0.008) </plain></SENT>
<SENT sid="8" pm="."><plain>This protective effect remained after adjustment for ethnicity </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: In SLE, IgM anti-ß(2)-GPI is not associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> but is protective against <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:hpo ids='HP_0000123'>nephritis</z:hpo> and renal damage. "Natural" autoantibodies of the IgM isotype may have a protective effect </plain></SENT>
</text></document>